scholarly journals Whole-genome screen identifies diverse pathways that negatively regulate ciliogenesis

2020 ◽  
pp. mbc.E20-02-0111
Author(s):  
Marion Failler ◽  
Ariadna Giro-Perafita ◽  
Mikito Owa ◽  
Shalini Srivastava ◽  
Chi Yun ◽  
...  

We performed a high-throughput whole-genome RNAi screen to identify novel inhibitors of ciliogenesis in normal and basal breast cancer cells. Our screen uncovered a previously undisclosed, extensive network of genes linking integrin signaling and cellular adhesion to the extracellular matrix with inhibition of ciliation in both normal and cancer cells. Surprisingly, a cohort of genes encoding extracellular matrix (ECM) proteins was also identified. We characterized several ciliation inhibitory genes and showed that their silencing was accompanied by altered cytoskeletal organization and induction of ciliation, which restricts cell growth and migration in normal and breast cancer cells. Conversely, supplying an integrin ligand, vitronectin, to the ECM rescued the enhanced ciliation observed upon silencing this gene. Aberrant ciliation could also be suppressed through hyper-activation of the YAP/TAZ pathway, indicating a potential mechanistic basis for our findings. Our findings suggest an unanticipated reciprocal relationship between ciliation and cellular adhesion to the extracellular matrix and provide a resource that could vastly expand our understanding of controls involving “outside-in” and “inside-out” signaling that restrain cilium assembly.

2015 ◽  
Vol 290 (14) ◽  
pp. 8722-8733 ◽  
Author(s):  
Raju R. Rayavarapu ◽  
Brendan Heiden ◽  
Nicholas Pagani ◽  
Melissa M. Shaw ◽  
Sydney Shuff ◽  
...  

Author(s):  
F. Vasaturo ◽  
C. Malacrino ◽  
E. Sallusti ◽  
G. Coppotelli ◽  
P. Birarelli ◽  
...  

2005 ◽  
Author(s):  
K. Hokeness ◽  
L. Qiu ◽  
M. Vezeridis ◽  
B. Yan ◽  
S. Mehta ◽  
...  

2016 ◽  
Vol 469 (1) ◽  
pp. 55-61 ◽  
Author(s):  
Shunhua Zhang ◽  
Cong Ma ◽  
Haijie Pang ◽  
Fanpeng Zeng ◽  
Long Cheng ◽  
...  

2019 ◽  
Vol 116 (15) ◽  
pp. 7353-7362 ◽  
Author(s):  
Cornelia Kröger ◽  
Alexander Afeyan ◽  
Jasmin Mraz ◽  
Elinor Ng Eaton ◽  
Ferenc Reinhardt ◽  
...  

Carcinoma cells residing in an intermediate phenotypic state along the epithelial–mesenchymal (E–M) spectrum are associated with malignant phenotypes, such as invasiveness, tumor-initiating ability, and metastatic dissemination. Using the recently described CD104+/CD44hi antigen marker combination, we isolated highly tumorigenic breast cancer cells residing stably—both in vitro and in vivo—in an intermediate phenotypic state and coexpressing both epithelial (E) and mesenchymal (M) markers. We demonstrate that tumorigenicity depends on individual cells residing in this E/M hybrid state and cannot be phenocopied by mixing two cell populations that reside stably at the two ends of the spectrum, i.e., in the E and in the M state. Hence, residence in a specific intermediate state along the E–M spectrum rather than phenotypic plasticity appears critical to the expression of tumor-initiating capacity. Acquisition of this E/M hybrid state is facilitated by the differential expression of EMT-inducing transcription factors (EMT-TFs) and is accompanied by the expression of adult stem cell programs, notably, active canonical Wnt signaling. Furthermore, transition from the highly tumorigenic E/M state to a fully mesenchymal phenotype, achieved by constitutive ectopic expression of Zeb1, is sufficient to drive cells out of the E/M hybrid state into a highly mesenchymal state, which is accompanied by a substantial loss of tumorigenicity and a switch from canonical to noncanonical Wnt signaling. Identifying the gatekeepers of the various phenotypic states arrayed along the E–M spectrum is likely to prove useful in developing therapeutic approaches that operate by shifting cancer cells between distinct states along this spectrum.


Sign in / Sign up

Export Citation Format

Share Document